Posts Tagged ‘biopharma’

Science Officers Lead The Way

Friday, March 12th, 2010
Chief Science Officers come from a variety of Science backrounds including Pharmacy

Chief Science Officers come from a variety of Science backrounds including Pharmacy

Science Officers Lead The Way in Irelands start up and established Pharmaceutical R&D companies. They provide the scientific backbone of R&D, Regulatory affairs and Pharmacovigilence activity where insight and understanding go hand in hand.

A typical Chief Science Officer will  manage and administer the actvities of other medical drug safety officers, science officers and technical personnel involved first hand in project engineering and the management of  other scientists who may also be Pharmacists engaged in the introduction of new drugs which will also involve vigilence reporting and monitoring of ADR’s and PSUR’s.

Irish Pharmaceutical enterprises are highly engaged in the latest Pharmaceutical drug research and development and it is through the technical and scientific know how of science officers that Ireland has gained significant FDI (Foreign Direct  Investment)

Eight out of ten major internationla biopharma and pharmaceutical multinationals have now sited here in Ireland and this is showing no sign of slowing yet despite the economic downturn.

Validating Quality Control

Thursday, February 4th, 2010
Validation Engineer Validating Medical Device Equipment

Validation Engineer Validating Medical Device Equipment

Validating Quality Control is essential for products being manufactured under extremely highly tolerances and to demanding Quality standards such as those found with medical device and pharmaceutical manufacture.

Validation is a quality control process that measures and tests against requirements that a system, product or service is achieving what it is required to do. For instance in manufacturing it is a process of zeroing equipment or plant to the exact parameters it must operate to, to produce product to an exact standard inorder to achieve a stated and fixed end result within fixed specifications outside of which it is not acceptable.

In essence it is  the process of fitness of purpose testing with the end user or other stake holders.

In many circumstances in manufacturing it can involve either computers, (hardware and software), equipment or an entire operating process or facility.

Validation in short can be explained by the question, “are you building the right thing?” and often requires reference to the Users Requirement Specifications or URS and the validation process can require a set of stringent protocols to achive completion referred to by the following terminology, IQ (Installation Qualification/OQ(Operational Qualification/Performance Qualification 

Opportunities  in Science jobs in Ireland today include positions for Validation Engineers, Validation Managers and Validation Document Control for a variety of industries and are readily found in high spec environments such as Biopharma, Pharmaceuticals, Semiconductors and Medical Device Manufacturing and are amongst some of the most highly paid science and engineering occupations availlable despite the current economic conditions.

Science Jobs are Engineering the Future

Thursday, January 7th, 2010
Science Jobs in Engineering

Science Jobs in Engineering

Science Jobs are engineering the future in Ireland today as the demand for R&D Engineers, Polymer Engineers, QA/RA Engineers and openings for senior professionals such as, Head of Research & Development,  Regulatory Affairs Specialists and Scientists continues to increase despite the economic downturn.

In particuar Research and Development investment from inward and outward sources has trebled in the past 10 years and is now at €2.6 billion or almost 1.7% of GNP. Intelectual property rights within the pharmaceutical, medical devices, software and ICT  manufacturing industries are now being given serious consideration as a major and strategic contributor to Ireland’s economy which as a revenue generator has a far greater long term financial generational potential than energy resource such as offshore oil and gas which todate have proved so far to be both costly and disappointing.

With the advent of the internet, Ireland has found its engineers and scientists research and design skills are now open for trade with the world and unlike natural resources are only limited by the numbers we educate and train in our universities and colleges.

To this end, Ireland has already begun a move away from depending on the goodwill or self interest of overseas multinationals and is now making provision for the future itself by strategically identifying those industries and markets worldwide that our native human resource skills can be applied to and to gain our financial share of  a global market that numbers in the Trillions of Euros.

As previously mentioned Ireland is already at an advanced stage of exploiting opportunities within the global nano technology markets that combine hybrid technolgies such as biopharma -nanobots, programable drugs and micro medical devices.

Instead of being discouraged by the limitations of what resources we have had in the past, Ireland is now positively assessing what we do have and the futher potential we have by shaping the world around us to our advantage to engineer the future.

After all  the description of Ireland in the past as that as the Island of Saints and Scholars is not far from what we would wish overseas investors seeing Ireland anew as, the Isle of R&D.

A New Year New Science Jobs

Monday, December 21st, 2009

A New Year and New Science Jobs are expected to increase. Last year American firms were the largest investors in

Intel- One of Ireland Inc's Largest R&D Investors

Intel- One of Ireland Inc's Largest R&D Investors

Ireland inc with nearly 2000 additional jobs created across a range of manufacturing and technical service sectors. The US has invested almost $150 Billion in Ireland in the past year with major investments from Intel, Boston Scientific, Teleflex, Pfizer, HP and Abbott to name a few. This investment is showing no immediate sign of diminishing.

Almost 100, 000 people are in full time emplopyment with US multinationals counting for almost 70% of IDA backed projects throughout Ireland with close to 600 firms covering Biopharma, medical devices, semiconductors, precision engineering, software, telecommunications, Pharmaceuticals, Project Management and Engineering  firms providing high end design and technical skills that will be the basis for Irelands future smart economy.

2009 was with out doubt one of the hardest years Ireland has endured economically but we possess a wealth of technical and knowledge based skills that translate and compete internationally with the best and brightest from the US, Germany, Japan and Singapore.

R&D invetsment in Ireland both Nationally and internationally has also grown which indicates a level of confidence in the future that looks beyond the recession we have experienced to date. We are definately not out of the woods yet but we can see through the trees to the light beyond. Knowledge will light the way to a brighter future.

Nanodevice Medical Devices Big News in Ireland

Monday, November 30th, 2009
NanoDevice Micromesh

NanoDevice Micromesh

Nanodevice Medical Devices Make Big News in Ireland. As previously mentioned on this blog, Medical devices continue to be a major center of growth and activity both in R&D and job creation for the Irish economy. But allied to this power house another developing science is begining to make itself felt. Nanoscience is rapidly converging and combining with the BioPharma and Medical device sectors which were once seen as distinct and completely sepperate branches of science and are now adding incredible synergies. Medical devices and biopharma products are now being enhanced and expanded far beyond their existing or previously envisioned applications into new and advanced medical or clinical applications. They have also opened up completly new research vistas undreamt of less than five years ago.

Nanoscience adds a different dimension or perhaps microdimension to products such as medical devices that allows them to operate at the subatomic level. For instance, as we see with most medical devices at present they operate as simple tools treating the symptoms of ailments whereas we are already witnessing the application of nanoscience to medical devices that will very soon  actually allow them to actively cure an illness.

Specifically we can envisage the usage of nano robots that can heal tears in arteries unreachable by contemporary surgery techniques. Additionally early research is already being undertaken with the development of gold plated nano drugs capable of functioning as effectively as a smart bio weapon, guided precisely and unerringly to the point of infection such as cancerous tumours doing away with debilitating chemo or radiation therapy.

Added together, medical devices, ICT and Biopharma employ over 130,000 people emphasising their importance to the nation as a significant economic driver. Given the global market for nanoscience products is over €3 Trillion Dollars, or to localise this figure, last year Ireland exported over €150 Billion in goods and services, of this 10% were nanoscience enabled or related products  or €15 Billion. By 2015 this figure could be as much as €30 Billion.

Small wonder then that as this sector continues to grow in importance, it will continue to be a beacon of hope in a time of unprecedented economic gloom.

R&D continues to witness increasing growth despite the downturn

Thursday, October 22nd, 2009
Research and Development in Biotechnology

Research and Development in Biotechnology

R&D continues to witness increasing growth despite the  downturn taking place in Ireland as new announcements have continued to be made by multinational companies involved in areas such as Medical Devices, Biopharma and Pharmaceutical manufacturing.

R&D or Research and Development has resulted in greater career prospects at home for Irelands science and technical professionals who continue to gain international respect for their work in fields as diverse as polymer technology, advanced medical products, telecommunications software and hardware.

As a result there has been a major increase in demand for R&D managers, R&D Engineers and Research associates carrying out front line research which has had the spin off effect of an increase in demand for Quality Assurance Managers and Engineers in addition to Regulatory Affairs professionals who form part of the collective support structure required for this ever increasing technical environment.

Recruitment is brisk and demand for science professionals for all these sectors is steadily increasing at a pace that seems to defy the current economic trend. Long may it continue